Ybpr Template Health Canada

Listing Websites about Ybpr Template Health Canada

Filter Type:

Yearly Biologic Product Report Template - annotated version

(9 days ago) A guide for sponsors of biologic drugs to prepare and submit YBPR to Health Canada. The template includes instructions, examples, and annotations for each section of the report. See more

https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/templates/yearly-biologic-product-report-annotated.html

Category:  Health Show Health

Yearly Biologic Product Report… The YBPR and you

(6 days ago) WEBYBPR format • Three options to consider: • Modify an existing annual report prepared for the FDA or EMEA to reflect the Canadian approval status • Prepare a Canadian-specific YBPR using the sections and bulleted points in Section 5.1.1 of the Guidance for format and content • Prepare a multi-product YBPR…similar products may be

https://capra.ca/_uploads/archive/presentations/13-NancyGreen-YBPRUpdate.pdf

Category:  Health Show Health

Guidance Document

(2 days ago) WEBHealth Canada is responsible for helping Canadians maintain and improve their health. It ensures that high-quality health services are accessible, and works to reduce health risks. Biologic Product Reports (YBPR), CTAs, CTA-Notifications (CTA-N) and CTA-Amendments (CTA-A). MFs may be referenced by more than one Applicant.

https://publications.gc.ca/collections/collection_2019/sc-hc/H164-267-2019-eng.pdf

Category:  Health Show Health

Biologics and Genetic Therapies Directorate

(4 days ago) WEBHealth Canada is the federal department responsible for helping the people of Canada maintain and improve their health. We assess the safety of drugs and many consumer products, help improve the safety of YBPR - Yearly Biologic Product Report . Documents . NOC - Notice of Compliance . NOC-c - Notice of Compliance with Conditions

https://www.publications.gc.ca/collections/collection_2019/sc-hc/H166-4-2019-eng.pdf

Category:  Health Show Health

Biologic and Radiopharmaceutical Drugs Directorate

(6 days ago) WEBAny questions or comments on this report should be forwarded to: Office of Submissions and Intellectual Property, Resource Management and Operations Directorate Finance Building, A.L. # 0202A1 101 Tunney’s Pasture Driveway, Tunney’s Pasture Ottawa, Ontario, K1A 0K9. Tel: (613) 941-7281 Fax: (613) 941-0825.

https://www.publications.gc.ca/collections/collection_2021/sc-hc/H162-5-2021-1-eng.pdf

Category:  Health Show Health

REP Templates for Health Canada

(2 days ago) WEBCompany (CO) Template (updated 2023-02-28) Required to obtain a company ID and/or update company information to Health Canada. Sent via email. Attach draft CO XML file to email prior to sending. Refer to section “2.3 Enrolment/Amendment Process” of the REP guidance document. Dossier ID Request Form for Human drugs and disinfectants.

https://health-products.canada.ca/rep-pir/index.html

Category:  Health Show Health

Biologics and Genetic Therapies Directorate

(Just Now) WEBAny questions or comments on this report should be forwarded to: Office of Submissions and Intellectual Property, Resource Management and Operations Directorate Finance Building, A.L. # 0202A1 101 Tunney’s Pasture Driveway, Tunney’s Pasture Ottawa, Ontario, K1A 0K9. Tel: (613) 941-7281 Fax: (613) 941-0825.

https://publications.gc.ca/collections/collection_2020/sc-hc/H2-2-2019-3-eng.pdf

Category:  Health Show Health

Standardized Health Product Risk Communication Template

(9 days ago) WEBAction taken by Health Canada. Text describing any risk management measures (e.g., [specific section] of the product monograph will be updated to reflect the new information) Report health or safety concerns. Managing marketed health product-related side effects depends on health care professionals and consumers reporting them.

https://www.hc-sc.gc.ca/dhp-mps/pubs/medeff/_guide/2010-guid-dir_indust_hppc-cpsp/2015-temp-mod_rc-cr-eng.php

Category:  Health Show Health

Biologics and Radiopharmaceutical Drugs Directorate

(5 days ago) WEBNAS Biontech Manufacturing GMBH 10-06-2021 16-09-2021. 8The CR Date is the date the submission is received and considered administratively complete by Health Canada. Biologics and Radiopharmaceutical Drugs Directorate - July 2022. BRDD Annual Drug Submission Performance ReportApril 1 2021 - March 31 2022.

https://www.smartbiggar.ca/docs/default-source/rx/biologics-and-radiopharmaceutical-drugs-directorate.pdf?sfvrsn=b25dd8dc_3/Biologics-and-Radiopharmaceutical-Drugs-Directorate

Category:  Health Show Health

Biologic and Radiopharmaceutical Drugs Directorate

(5 days ago) WEBAny questions or comments on this report should be forwarded to: Office of Submissions and Intellectual Property Resource Management and Operations Directorate Finance Building, A.L. # 0202A1 101 Tunney’s Pasture Driveway, Tunney’s Pasture Ottawa, Ontario, K1A 0K9. Tel: (613) 941-7281 Fax: (613) 941-0825.

https://www.smartbiggar.ca/docs/default-source/rx/brdd_dmbr_2019_20_annual_annuel_eng_revised.pdf?sfvrsn=42a2e061_2

Category:  Health Show Health

Health Canada Lot Release Program for Biologic Drugs

(4 days ago) WEB1.2 The Lot Release Program. Each lot of a Schedule D (biologic) drug is subject to the Lot Release Program before sale1 in Canada. The risk-based Lot Release Program covers both pre- and post-market stages. The Lot Release Program derives its legislative authority from section C.04.015 of the Food and Drug Regulations2.

https://ntp.niehs.nih.gov/sites/default/files/iccvam/methods/biologics/vaccine/canada-lotreleaseprgm.pdf

Category:  Food Show Health

SPharm Canada - Canada's Regulatory Experts for Drug & Health …

(4 days ago) WEBYearly Biologic Product Report – YBPR. A report that must be submitted annually by manufacturers of all Schedule D (Biologic) drugs in accordance with Guidance for Sponsors: Lot Release Program for Schedule D (Biologics) Drugs. (Health Canada’s template per study phase). Health Canada reviews the CTA and notifies the sponsor …

https://spharm-inc.com/author/spharm-canada/

Category:  Health Show Health

Biologic and Radiopharmaceutical Drugs Directorate

(2 days ago) WEBTel: (613) 941-7281 Fax: (613) 941-0825. Email: [email protected]. 6For further clarification refer to the Guidance for Industry: Management of Drug Submissions. Biologic and Radiopharmaceutical Drugs Directorate - December 2021.

https://publications.gc.ca/collections/collection_2022/sc-hc/H162-5-2021-2-eng.pdf

Category:  Health Show Health

Canadian Association of Professionals in Regulatory Affairs

(5 days ago) WEBPK !ã8È$t â [Content_Types].xml ¢ ( ęێÓ0 †ï‘x‡È·¨qíÀ² ¦{ÁáŠÃJ, `’ikHl+vËöíqÒ Ù*KèºÖÜTr’™ùÆiÿqgf7÷u•l ±R«œ°tJ P

https://capra.ca/_uploads/archive/presentations/5-ybpr-template_mnemec.pptx

Category:  Health Show Health

Guidance Document

(2 days ago) WEBHealth Canada is responsible for helping Canadians maintain and improve their health. It ensures that high-quality health services are accessible, and works to reduce health risks. Également disponible en français sous le titre : Ligne directrice Préparation des activités de réglementation en format Electronic Common Technical Document (eCTD)

https://publications.gc.ca/collections/collection_2021/sc-hc/H164-293-2019-eng.pdf

Category:  Health Show Health

Filter Type: